Sign In
Buy BIIB
$207.94
+1.66 (+0.80%)
At Close: Aug 07, 2026
Biogen's Alzheimer's Drug Likely To Be Approved With Warning Labels
01:41pm, Thursday, 29'th Dec 2022
A new as-yet-unreported death among those taking Biogen's Lecanemab in an extended post-Phase 3 study has emerged. Biogen's Lecanemab has a PDUFA date of January 6, 2023; the FDA will announce its pre
Congressional report: U.S. FDA broke own protocols in approving Biogen Alzheimer's drug
01:05pm, Thursday, 29'th Dec 2022
The U.S. Food and Drug Administration failed to adhere to its own guidance and internal practices during the approval process for Biogen's Alzheimer's drug Aduhelm, which was "rife with irregularities
Biogen Inc. (BIIB) Stock Moves -0.27%: What You Should Know
11:00pm, Wednesday, 28'th Dec 2022 Zacks Investment Research
Biogen Inc. (BIIB) closed at $274.04 in the latest trading session, marking a -0.27% move from the prior day.
Is Biogen's Stock Too Risky to Invest in?
12:45pm, Wednesday, 28'th Dec 2022 The Motley Fool
Even at a discount, investors may be taking on a big risk with Biogen.
The Top Three Stocks Analysts Say To Buy
10:20am, Wednesday, 28'th Dec 2022
The analysts are rewarding companies that prove they can succeed in the face of headwinds and the most upgraded in Q4 2022 are Netflix, Biogen and Nike.
Is Biogen's Stock Too Risky to Invest in?
07:45am, Wednesday, 28'th Dec 2022
Even at a discount, investors may be taking on a big risk with Biogen.
Roche's (RHHBY) Lunsumio Gets FDA Nod for Follicular Lymphoma
03:05pm, Friday, 23'rd Dec 2022 Zacks Investment Research
Following the FDA's approval, Roche (RHHBY) Lunsumio is the first CD20xCD3 T-cell engaging bispecific antibody approved to treat follicular lymphoma.
3 Nasdaq Stocks That Are Up 25% in 3 Months
02:53pm, Friday, 23'rd Dec 2022 The Motley Fool
Should you jump on the bandwagon and buy these surging stocks?
1 Green Flag and 1 Red Flag for Biogen
11:30am, Friday, 23'rd Dec 2022 The Motley Fool
Biogen beat the bear market this year.
3 Nasdaq Stocks That Are Up 25% in 3 Months
09:53am, Friday, 23'rd Dec 2022
Should you jump on the bandwagon and buy these surging stocks?
1 Green Flag and 1 Red Flag for Biogen
06:30am, Friday, 23'rd Dec 2022
Biogen beat the bear market this year.
Has This Top Pharma Company Found Its Next Billion-Dollar Product?
09:53am, Thursday, 22'nd Dec 2022
Eli LIlly is looking to make waves in an important therapeutic area.
The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond
09:04am, Sunday, 18'th Dec 2022
Major indices such as the S&P 500 and the Nasdaq Composite may have plunged by double-digits during 2022, but certain areas of the stock market performed strongly throughout the year. One of those
Buying These Unstoppable Stocks Before 2023 Could Be a Genius Move
06:45am, Sunday, 18'th Dec 2022
These stocks have climbed by double digits this year.
